A therapy of the bronchial asthma should include medicines for the emergency reduction of bronchospasm and the background therapy. The preventive therapy of the bronchial asthma is based on the use of glucocorticosteroids because only hormonal products are able to restore the respiratory function of a human.
As a rule, to reduce the acute bronchospasm, the inhalant products are used: Salbutamol, Salmeterol, and Fluticasone. However, these drugs are ineffective during the background therapy. A neglect of the principles of the background therapy of the bronchial asthma conduces to the obstruction of the airway tracts, and a reduction of the vital capacity.
Prednisolone is one of the best products to have the background therapy of the bronchial asthma. It has been proved that Prednisolone effectively inhibits the inflammatory processes in the airway tracts and inhibits an acute reaction of the immune system to the action of the external irritants. It means that it controls the internal processes and prevents the frequent cause of the development of the bronchial spasms – the effect of allergens.
A complex action of Prednisolone helps to better control the symptoms of the bronchial asthma and reduce the frequency of the asthma attacks. It is clinically proved that the use of Prednisolone reduces the structural changes in the airway tracts and keeps the vital capacity. Despite the fact that this product is not released in the form of the solution for inhalation, the oral form of Prednisolone gives good results in 2-3 days after the started treatment.
Prednisolone is used as a maintaining prolonged therapy to keep the main function of bronchi and airway tracts. It is not prescribed to reduce the bronchial spasms. It interacts well with agonists of beta 2 receptors that provide a rapid anti-inflammatory effect. As the practice shows, these symptoms as hissing, asphyxia, severe cough, and difficult breathing are reduced in a week after the started treatment.
In 2-3 weeks of the Prednisolone use, a patient with the bronchial asthma is able to increase the physical activity, and the inflammatory reaction does not appear often in the respiratory system as a reaction to the action of allergens: cigarette smoke, pollen, and cool air.
But a stable maintaining effect is achieved only during the prolonged or permanent use of Prednisolone depending on a severity of the asthma and how intensively the obstruction of the respiratory tracts is.
A standard prescription of Prednisolone passes with minimal number of the side effects during the allergic or inflammatory reaction. As the treatment usually takes for several months, none serious changes happen in the physiological processes.
However, patients have to take Prednisolone within several years to treat the bronchial asthma. Due to this, the side effects may occur. A patient may have the following side effects within the first several weeks or months of Prednisolone use:
These symptoms may be light, and if the doctor’s recommendations are observed, they quickly pass without a medical intervention.
But taking the drug for more than 5-6 months, more intensive symptoms may appear, such as:
Bear in mind that Prednisolone excretes calcium and potassium from the body. In the first case, a patient may have brittleness of the bones and osteoporosis, and in the second case, the pathologies in the cardiovascular system grow.
Any side effect is not normal, and if the symptoms do not pass within 2-3 days, it is necessary to visit a doctor who has prescribed you Prednisolone. It may happen that the doctor may have prescribed you a high dose, or you have a high sensitivity to this drug.
The dose of Prednisolone depends on a severity of the clinical symptoms in the treatment. In case of the acute types of the bronchial asthma with frequent attacks and permanent inflammatory processes, it is necessary to take a high dose of Prednisolone 30-40 mg per day. It is the optimal initial dose that may stop the progress of the disease, and a patient will be able to reconsider the treatment.
In rare cases, patients with the bronchial asthma need an increase of the working dose up to 50-60 mg per day. The drug in this high dose should be taken for a short period of time up to having the first success in the treatment.
If a patient takes any medicines for the background therapy of the bronchial asthma but the scheme of the treatment should be changed, Prednisolone is prescribed in the dose of 10-15 mg per day. This maintaining therapy will control a production of the inflammation mediators, and the allergy will prevent the disease development.
Admittedly, besides the use of Prednisolone, it is necessary to take medications for the urgent arresting of the asthma attacks. Many drugs contain glucocorticoids.
The pharmacological action will grow during the interaction of two drugs from one medical group. Therefore, the dose of Prednisolone should be reduced as less priority in comparison with the inhalers to reduce the attack. If the inhaler does not contain glucocorticoids, a change of the Prednisolone dose is not required.
There is an opinion that the use of Prednisolone in the treatment of the bronchial asthma should not be daily. It is enough to take the pills 3 times per week in order to minimize a probability of the side effects. This scheme is useful in individual cases when the metabolism of Prednisolone is slow, and the symptoms of the bronchial asthma are light.
But most patients have to take Prednisolone every day. The daily use of the pills may keep a stable anti-inflammatory and immunodepressive effect required to control the manifestations of the bronchial asthma.
Moreover, it does not matter how long you take the pills: 1 month, 1 year, or 5 years. You have to follow the dosing and take the medicine on a regular basis, without skipping a dose.
Every second patient with chronic bronchitis is subject to the bronchial asthma. An undertreated bronchitis is often a cause of the bronchial obstruction which is accompanied by such symptoms as breathlessness, hissing during breathing, difficult breathing, and difficult discharge of begma.
In case of the severe bronchitis, temporal bronchial spasms may occur, and they are accompanied by the edema of the mucus of bronchi. Prednisolone is prescribed during this type of bronchitis.
Prednisolone is not recommended during light types of bronchitis that may be treated by the bronchodilator products, or mucolytic drugs. This hormonal drug is used only during the worsening of the respiratory function due to the standard non-hormonal therapy.
If Prednisolone is prescribed, the other medications are cancelled. If bronchitis has a bacterial origin, the antibacterial or antiviral therapy is done at first, and then Prednisolone is prescribed.
The use of Prednisolone for bronchitis helps to reduce the obstructive processes in bronchi, remove edema from bronchi and respiratory tracts, and also increase the discharge of sputum. The modern therapy with Prednisolone will help to prevent a transformation of the chronic bronchitis into the bronchial asthma.
Note! Do not take Prednisolone on your own, during the first symptoms of bronchitis. Only professional doctor can prescribe this drug, and only doctor may know that Prednisolone will not cause side effects in your clinical case.